Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Marnie L. Boron"'
Autor:
E.C. Faulkner, Ion Cotarla, Daryl S. Spinner, Adam Yagui-Beltran, Marissa C. Carroll, Marnie L. Boron, Shawna L. Cullen, Surbhi Shah
Publikováno v:
JCO oncology practice. 16(10)
PURPOSE: We conducted a cross-sectional survey of practicing medical oncologists in the United States to obtain insight into physician and patient treatment decision making in stage III non–small-cell lung cancer (NSCLC). METHODS: A convenience sam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d0eeb75f981ac45b7080f9915c1be84
https://pubmed.ncbi.nlm.nih.gov/32574126
https://pubmed.ncbi.nlm.nih.gov/32574126
Autor:
Catherine Balderston McGuiness, Karma M. Rabon-Stith, Brett Saunders, Laurel Edelman, Marnie L. Boron, Veena R. Kumar
Publikováno v:
The Pediatric Infectious Disease Journal
Background: Annual respiratory syncytial virus (RSV) outbreaks throughout the US exhibit variable patterns in onset, peak month of activity and duration of season. RSVAlert®, a US surveillance system, collects and characterizes RSV test data at nati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16f93eae3e4d5f851911eca62f3fe287
https://doi.org/10.1097/inf.0000000000000257
https://doi.org/10.1097/inf.0000000000000257
Autor:
Marnie L. Boron, Shawna L. Cullen, E.C. Faulkner, Marissa C. Carroll, Daryl S. Spinner, Surbhi Shah, Kellie Ryan, Ion Cotarla, Adam Yagui-Beltran
Publikováno v:
Journal of Clinical Oncology. 37:35-35
35 Background: Clinical guidelines seek to optimize patient care. We investigated how oncologists manage stage III non-small cell lung cancer (NSCLC) patients from diagnosis through treatment decision-making and drivers impacting guideline adherence.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f860101c39d76ac31b24ee16d7a29173
https://doi.org/10.1200/jco.2019.37.27_suppl.35
https://doi.org/10.1200/jco.2019.37.27_suppl.35
Autor:
Karma M. Rabon-Stith, Brett Saunders, Laurel Edelman, Catherine Balderston McGuiness, Marnie L. Boron, Veena R. Kumar
Publikováno v:
Journal of Clinical Virology. 58(3):575-578
Background Antigen detection tests have been the most common diagnostic assay used to detect and diagnose respiratory syncytial virus (RSV). The utility and increased sensitivity of polymerase chain reaction (PCR) tests have been reported; however, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4961cb804c5176bb48e851db300c2e63
Autor:
Marnie L. Boron, Cliff Nerwen, Paul VanVeldhuisen, Jessie R. Groothuis, Michael Frogel, Molly Harrington, Alan H. Cohen
Publikováno v:
Pediatric Infectious Disease Journal. 27:870-873
BACKGROUND Palivizumab Outcomes Registry data collected during 4 years were examined to assess compliance and respiratory syncytial virus (RSV) hospitalization rates in high-risk children receiving palivizumab prophylaxis at home compared with an out
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d0d741e376d657b7c8dc5d0b55a249f
https://doi.org/10.1097/inf.0b013e318174e0c4
https://doi.org/10.1097/inf.0b013e318174e0c4
Autor:
Stuart A. Cohen, Robert Zanni, Marnie L. Boron, Paul VanVeldhuisen, Alan H. Cohen, Molly Harrington
Publikováno v:
Pediatric Cardiology. 29:382-387
The Palivizumab Outcomes Registry prospectively collected data on 19,548 subjects who received respiratory syncytial virus (RSV) prophylaxis with palivizumab during the 2000-2004 RSV seasons. We evaluated the characteristics of enrolled registry subj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7231c00925b7f20f0f9face1c7dd803
https://doi.org/10.1007/s00246-007-9039-5
https://doi.org/10.1007/s00246-007-9039-5
Publikováno v:
Pediatric Infectious Disease Journal. 27:559-561
The Palivizumab Outcomes Registry collected data on 19,548 high-risk infants who received > or =1 dose of palivizumab and followed prospectively from 2000 through 2004. Ninety-one children with cystic fibrosis (CF) were identified who received palivi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce4a22ef17f29c6eff751c8f137de3b4
https://doi.org/10.1097/inf.0b013e3181673c15
https://doi.org/10.1097/inf.0b013e3181673c15
Publikováno v:
The Pediatric infectious disease journal. 27(12)
Background: To characterize the onset, peak, and duration of the RSV season in major metropolitan areas in the United States as determined from laboratory test data collected by a novel RSV surveillance program (RSV Alert), including regional and nat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9f565d98f30703121267da97acdb661
https://pubmed.ncbi.nlm.nih.gov/18989237
https://pubmed.ncbi.nlm.nih.gov/18989237
Publikováno v:
Journal of perinatology : official journal of the California Perinatal Association. 28(7)
The Palivizumab Outcomes Registry contains data on infants and young children who received palivizumab for the prevention of respiratory syncytial virus (RSV) that causes serious lower respiratory tract illness.Prospective observational registry enro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3a48c5bdc1e779ec88caed76d12c001
https://pubmed.ncbi.nlm.nih.gov/18368063
https://pubmed.ncbi.nlm.nih.gov/18368063
Autor:
Niki L. Oquist, Alan H. Cohen, Wm. Brendle Glomb, Molly Rankin, Marnie L. Boron, Bennie McWilliams
Publikováno v:
Chest. 126:777S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7a6fd309427a15f70b70ef7b453189a
https://doi.org/10.1378/chest.126.4_meetingabstracts.777s-b
https://doi.org/10.1378/chest.126.4_meetingabstracts.777s-b